Mapping Evidence of Pharmacy Services for COVID-19 in China

ObjectiveTo explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China.MethodsWe comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy se...

Full description

Bibliographic Details
Main Authors: Zhan-Miao Yi, Yang Hu, Guan-Ru Wang, Rong-Sheng Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.555753/full
id doaj-1bf514f94d024dd987053429eea13a91
record_format Article
spelling doaj-1bf514f94d024dd987053429eea13a912020-11-25T03:55:36ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-10-011110.3389/fphar.2020.555753555753Mapping Evidence of Pharmacy Services for COVID-19 in ChinaZhan-Miao Yi0Zhan-Miao Yi1Zhan-Miao Yi2Yang Hu3Yang Hu4Yang Hu5Yang Hu6Guan-Ru Wang7Guan-Ru Wang8Guan-Ru Wang9Guan-Ru Wang10Rong-Sheng Zhao11Rong-Sheng Zhao12Rong-Sheng Zhao13Department of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaObjectiveTo explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China.MethodsWe comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy services for COVID-19 patients using a predefined search strategy. The search period was from inception to April 7th 2020. We also manually searched the reference list of included articles and websites of important journals with special issues for COVID-19.ResultsA total of 156 articles were identified by applying the search criteria. After screening, 91 articles, with the majority are literature reviews (n = 77, 84.62%) published in Chinese (n = 83, 91.2%), were included. Pharmacist interventions for COVID-19 patients most commonly related to guidelines or consensus development for the treatment of disease and practice procedure to prevent the spread of COVID-19 (n = 10, 10.98%), the supply of medicines to treat patients with severe respiratory or systematic symptoms related to COVID-19 (n = 10, 10.98%), formulating infections prevention and control strategies related to COVID-19 for pharmaceutical personnel/pharmacy staff (n = 14, 15.39%), new way of delivery pharmacy services and the implementation of new pharmacy services for COVID-19 outbreak (n = 14, 15.39%), routine pharmacy services under the restrict limit of COVID-19 outbreak (n = 39, 42.86%), and case series analysis of treatment regimens using existing, routinely collected data (n = 4, 4.40%).ConclusionPharmacy services have a role in the COVID-19 pandemic control, and there were many rapid changes in response to the pandemic.https://www.frontiersin.org/article/10.3389/fphar.2020.555753/fullCOVID-19pharmacy serviceguideline developmentemergency supplyservice model innovationtreatment regimens
collection DOAJ
language English
format Article
sources DOAJ
author Zhan-Miao Yi
Zhan-Miao Yi
Zhan-Miao Yi
Yang Hu
Yang Hu
Yang Hu
Yang Hu
Guan-Ru Wang
Guan-Ru Wang
Guan-Ru Wang
Guan-Ru Wang
Rong-Sheng Zhao
Rong-Sheng Zhao
Rong-Sheng Zhao
spellingShingle Zhan-Miao Yi
Zhan-Miao Yi
Zhan-Miao Yi
Yang Hu
Yang Hu
Yang Hu
Yang Hu
Guan-Ru Wang
Guan-Ru Wang
Guan-Ru Wang
Guan-Ru Wang
Rong-Sheng Zhao
Rong-Sheng Zhao
Rong-Sheng Zhao
Mapping Evidence of Pharmacy Services for COVID-19 in China
Frontiers in Pharmacology
COVID-19
pharmacy service
guideline development
emergency supply
service model innovation
treatment regimens
author_facet Zhan-Miao Yi
Zhan-Miao Yi
Zhan-Miao Yi
Yang Hu
Yang Hu
Yang Hu
Yang Hu
Guan-Ru Wang
Guan-Ru Wang
Guan-Ru Wang
Guan-Ru Wang
Rong-Sheng Zhao
Rong-Sheng Zhao
Rong-Sheng Zhao
author_sort Zhan-Miao Yi
title Mapping Evidence of Pharmacy Services for COVID-19 in China
title_short Mapping Evidence of Pharmacy Services for COVID-19 in China
title_full Mapping Evidence of Pharmacy Services for COVID-19 in China
title_fullStr Mapping Evidence of Pharmacy Services for COVID-19 in China
title_full_unstemmed Mapping Evidence of Pharmacy Services for COVID-19 in China
title_sort mapping evidence of pharmacy services for covid-19 in china
publisher Frontiers Media S.A.
series Frontiers in Pharmacology
issn 1663-9812
publishDate 2020-10-01
description ObjectiveTo explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China.MethodsWe comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy services for COVID-19 patients using a predefined search strategy. The search period was from inception to April 7th 2020. We also manually searched the reference list of included articles and websites of important journals with special issues for COVID-19.ResultsA total of 156 articles were identified by applying the search criteria. After screening, 91 articles, with the majority are literature reviews (n = 77, 84.62%) published in Chinese (n = 83, 91.2%), were included. Pharmacist interventions for COVID-19 patients most commonly related to guidelines or consensus development for the treatment of disease and practice procedure to prevent the spread of COVID-19 (n = 10, 10.98%), the supply of medicines to treat patients with severe respiratory or systematic symptoms related to COVID-19 (n = 10, 10.98%), formulating infections prevention and control strategies related to COVID-19 for pharmaceutical personnel/pharmacy staff (n = 14, 15.39%), new way of delivery pharmacy services and the implementation of new pharmacy services for COVID-19 outbreak (n = 14, 15.39%), routine pharmacy services under the restrict limit of COVID-19 outbreak (n = 39, 42.86%), and case series analysis of treatment regimens using existing, routinely collected data (n = 4, 4.40%).ConclusionPharmacy services have a role in the COVID-19 pandemic control, and there were many rapid changes in response to the pandemic.
topic COVID-19
pharmacy service
guideline development
emergency supply
service model innovation
treatment regimens
url https://www.frontiersin.org/article/10.3389/fphar.2020.555753/full
work_keys_str_mv AT zhanmiaoyi mappingevidenceofpharmacyservicesforcovid19inchina
AT zhanmiaoyi mappingevidenceofpharmacyservicesforcovid19inchina
AT zhanmiaoyi mappingevidenceofpharmacyservicesforcovid19inchina
AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina
AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina
AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina
AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina
AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina
AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina
AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina
AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina
AT rongshengzhao mappingevidenceofpharmacyservicesforcovid19inchina
AT rongshengzhao mappingevidenceofpharmacyservicesforcovid19inchina
AT rongshengzhao mappingevidenceofpharmacyservicesforcovid19inchina
_version_ 1724469201468391424